| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Enxing Seng Stacy | Director | 20 EASTBOURNE TERRANCE, LONDON, UNITED KINGDOM | /s/ Sarah K. Mohr, Attorney-in-Fact | 2025-06-17 | 0001329921 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LIVN | Ordinary Shares | Options Exercise | $0 | +3.42K | +39.06% | $0.00 | 12.2K | Jun 15, 2025 | Direct | F1, F2 |
| transaction | LIVN | Ordinary Shares | Tax liability | -$18.8K | -410 | -3.37% | $45.76 | 11.8K | Jun 15, 2025 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LIVN | Restricted Stock Units | Options Exercise | $0 | -3.42K | -100% | $0.00 | 0 | Jun 15, 2025 | Ordinary Shares | 3.42K | Direct | F2, F4 | |
| transaction | LIVN | Restricted Stock Units | Award | $0 | +4.04K | $0.00 | 4.04K | Jun 15, 2025 | Ordinary Shares | 4.04K | Direct | F5, F6 |
| Id | Content |
|---|---|
| F1 | Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. |
| F2 | Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the 2015 Plan award agreement. |
| F3 | Shares withheld to satisfy tax liability. |
| F4 | RSUs granted under the 2015 Plan on June 15, 2024 that vested on June 15, 2025. |
| F5 | Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. |
| F6 | The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. |